OPINIONJim Cramer -- Valeant's Sales Struggles Mean Allergan Could ProfitBy Bret KenwellNov 17, 2015 10:49 AM EST
MERGERS AND ACQUISITIONSPfizer's Bid for Allergan May Be Too Good to Turn DownBy Scott StuartOct 29, 2015 5:56 PM EDT
INVESTINGAllergan Beats Earnings, Delays Forecast Until Next QuarterBy TheStreetAug 6, 2015 2:25 PM EDT
VIDEOAllergan Beats Estimates, Company to Update Guidance Next QuarterBy TheStreet StaffAug 6, 2015 12:29 PM EDT
INVESTINGWhat to Watch Thursday -- Trump, Bush, Allergan Earnings, Jobless ClaimsBy U-Jin LeeAug 5, 2015 8:15 PM EDT
OPINIONJim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, WayfairBy Margo BellerJun 19, 2015 6:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally TodayBy Bret KenwellJun 18, 2015 8:49 PM EDT
OPINIONJim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, AlkermesBy Margo BellerJun 18, 2015 6:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet YellenBy Chris SahlJun 17, 2015 8:43 PM EDT
OPINION5 Stocks on Traders' Radars -- and What You Should Do With ThemBy Jonas ElmerrajiJun 17, 2015 2:53 PM EDT
MARKETSStocks Recover; Yellen Sees Residual Weakness in Labor MarketBy Keris Alison LahiffJun 17, 2015 2:42 PM EDT
MARKETSCrude Oil Boosts Stocks as Domestic Inventories FallBy Keris Alison LahiffJun 17, 2015 10:59 AM EDT
OPINIONJim Cramer -- Let's Face It, Allergan's Kythera Acquisition Is 'Brilliant'By Bret KenwellJun 17, 2015 10:49 AM EDT
MARKETSKythera Biopharma (KYTH) Stock Soaring; Jim Cramer Calls Allergan Deal 'Brilliant'By Kurumi FukushimaJun 17, 2015 9:32 AM EDT
MARKETSStock Futures Are Mixed as Investors Await Fed AnnouncementBy Keris Alison LahiffJun 17, 2015 8:33 AM EDT
MARKETSAllergan (AGN) Stock May Trade Higher; Jim Cramer Calls Kythera Acquisition 'Brilliant'By Kurumi FukushimaJun 17, 2015 8:26 AM EDT
JIM CRAMER'Mad Money' Lightning Round: DreamWorks Animation Is Dead MoneyBy Scott RuttJun 11, 2015 11:49 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: There Was Good News Out There TodayBy Scott RuttJun 10, 2015 8:25 PM EDT
OPINIONJim Cramer -- Kythera Biopharmaceuticals Is Proving the Bears WrongBy Bret KenwellJun 10, 2015 11:13 AM EDT
JIM CRAMER'Mad Money' Lightning Round: Sell, Sell, Sell Protein Design LabsBy Scott RuttMay 22, 2015 6:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: Snap Judgments Will Cost YouBy Scott RuttMay 21, 2015 8:27 PM EDT
